Divalproex sodium extended-release tablets for migraine prophylaxis in adolescents: An open-label, long-term safety study

被引:0
|
作者
Apostol, George
Lewis, Donald
Laforet, Genevieve A.
Robieson, Weining Z.
Fugate, Julie M.
Abi-Saab, Walid
Rappard, Fred
Saltarelli, Mario
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A475 / A476
页数:2
相关论文
共 50 条
  • [1] Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study
    Apostol, George
    Lewis, Donald W.
    Laforet, Genevieve A.
    Robieson, Weining Z.
    Fugate, Julie M.
    Abi-Saab, Walid M.
    Saltarelli, Mario D.
    [J]. HEADACHE, 2009, 49 (01): : 45 - 53
  • [2] Safety and Tolerability of Divalproex Sodium Extended-Release in the Prophylaxis of Migraine Headaches: Results of an Open-Label Extension Trial in Adolescents
    Apostol, George
    Pakalnis, Ann
    Laforet, Genevieve A.
    Robieson, Weining Z.
    Olson, Evelyn
    Abi-Saab, Walid M.
    Saltarelli, Mario
    [J]. HEADACHE, 2009, 49 (01): : 36 - 44
  • [3] A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis
    Freitag, FG
    Collins, SD
    Carlson, HA
    Goldstein, J
    Saper, J
    Silberstein, S
    Mathew, N
    Winner, PK
    Deaton, R
    Sommerville, K
    [J]. NEUROLOGY, 2002, 58 (11) : 1652 - 1659
  • [4] The safety and efficacy of divalproex sodium extended-release tablets in migraine prophylaxis: A double-blind, placebo-controlled study in adolescents
    Apostol, G.
    Cady, R. K.
    Laforet, G. A.
    Robieson, W. Z.
    Olson, E. M.
    Abi-Saab, W. M.
    Saltarelli, M. D.
    [J]. ANNALS OF NEUROLOGY, 2007, 62 : S127 - S127
  • [5] Divalproex sodium extended-release for the prophylaxis of migraine headache
    Freitag, FG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (09) : 1573 - 1578
  • [6] Long-Term Safety of Divalproex Sodium Extended-Release in Children and Adolescents with Bipolar I Disorder
    Redden, Laura
    DelBello, Melissa
    Wagner, Karen Dineen
    Wilens, Timothy E.
    Malhotra, Shishuka
    Wozniak, Patricia
    Vigna, Namita V.
    Greco, Nicholas
    Kovacs, Xenia
    Abi-Saab, Walid
    Saltarelli, Mario
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (01) : 83 - 89
  • [7] Long-Term Safety of Paliperidone Extended Release in Adolescents with Schizophrenia: An Open-Label, Flexible Dose Study
    Savitz, Adam
    Lane, Rosanne
    Nuamah, Isaac
    Singh, Jaskaran
    Hough, David
    Gopal, Srihari
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (07) : 548 - 557
  • [8] Open-label long-term use of divalproex sodium in headache
    Diamond, S
    Freitag, FG
    Diamond, ML
    Urban, GJ
    Pepper, BJ
    Bhambhavani, D
    [J]. HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH, 1997, 8 (01): : 42 - 44
  • [9] Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder
    Emslie, Graham J.
    Yeung, Paul P.
    Kunz, Nadia R.
    [J]. CNS SPECTRUMS, 2007, 12 (03) : 223 - 233
  • [10] Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain
    Pascual, Maria Luz G.
    Fleming, Rosa Rosanna B.
    Gana, Theolphilus J.
    Vorsanger, Gary J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2531 - 2542